PharmStars

Neuroventis is a digital platform focused on neurology, designed to assist patients in managing their neurological disorders. The platform operates as a CE-marked medical device, allowing users to register their health conditions and share relevant data with their medical teams. By enhancing the interaction between patients and healthcare professionals, Neuroventis aims to empower patients to take an active role in their health management. This approach fosters stronger partnerships in clinical practice and supports patients in overcoming the challenges associated with their conditions.

Orbit Health is a health technology company that develops an artificial intelligence platform aimed at improving the management of chronic diseases, particularly Parkinson's disease. The platform offers continuous and objective insights into motor symptoms by utilizing smartwatch motion data, which is passively collected without disrupting patients' daily activities. This data allows physicians to tailor treatment plans, enabling patients to achieve optimal symptom control and enhance their quality of life. By focusing on the personalization of treatment, Orbit Health seeks to address the unique needs of individuals living with Parkinson's disease.

REACT Neuro develops artificial intelligence based digital healthcare platform for brain health. The company’s platform supports biomarkers and helps to understand patient’s brain health based on clinically validated peer reviewed exams. The company is based in Cambridge, Massachusetts.

HealthQb is a company that focuses on remotely monitoring the biopsychosocial health of patients, particularly those with chronic illnesses. It provides a behavior modification system that utilizes wearables or smartwatches, accompanied by a patient application and healthcare portal. This technology enables healthcare providers, including physiotherapists and other practitioners, to access objective assessments of their patients' health. By doing so, they can guide patients towards achieving their health goals and addressing the root causes of unhealthy behaviors. HealthQb's approach aims to empower both patients and healthcare professionals in the management and improvement of health outcomes.

Deliberate AI is a developer of technology focused on behavioral and mental health care applications. The company has created a platform that employs artificial intelligence algorithms to deliver regulatory-grade objective measurements. This technology supports diagnostics, monitoring, and data insights specifically tailored for mental and neurological healthcare, as well as clinical trials. By providing clinicians, physicians, and healthcare researchers with reliable, data-driven tools, Deliberate AI enhances the ability to diagnose and monitor mental health conditions effectively.

Developer of an AI-based digital therapeutics platform designed for the prevention, prediction, and monitoring of chronic neurodegenerative diseases. The company uses AI and machine learning to detect changes in patients with chronic neurological conditions such as multiple sclerosis and falling risk in elderly patients, enabling patients to monitor their daily health-related activities with a user-friendly experience and reduce their ongoing treatment costs.

WKD.SMRT provides a platform that combines remote interaction with state-of-the-art digital technologies to deliver accurate and complete real-world data. They integrates data in the home with third party data and conventional clinical examinations.

Developer of an AI-powered neurodiagnostic software intended for clinicians to treat dementia patients. The company's platform analyzes EEG data to identify brainwave patterns that are associated with the onset or progression of Alzheimer's and dementia conditions, enabling clinicians to conduct earlier and more efficient clinical trials, while accelerating the development of effective treatments.

Head Diagnostics is a life sciences technology company that specializes in the development of a non-invasive medical device designed to assess and evaluate brain impairment and disease. This innovative device allows for rapid assessment of concussions without the need for an initial baseline test, providing objective evaluations. By delivering real-time neuro data to hospitals, neurologists, physicians, and patients, Head Diagnostics aims to enhance patient outcomes and reduce reliance on traditional imaging methods such as CT scans.

Accexible focuses on the development of technology that extracts acoustic characteristics from the speech of a person who gives us clues to his health and well-being. Accexible identifies vocal biomarkers, specific characteristics of the voice that indicate various health conditions, for the diagnosis and monitoring of diseases

Nori Health operates a healthcare platform designed to provide personalized support for individuals living with chronic diseases, particularly those with inflammatory bowel disease. The platform features a chatbot that engages users in regular conversations, helping them identify and modify lifestyle factors that may exacerbate their condition. By facilitating these lifestyle changes, Nori Health aims to improve patients' overall quality of life and alleviate symptoms such as fatigue, pain, and anxiety. The service focuses on empowering users to take control of their health through tailored guidance and support.

The Clinician Ltd is a health technology company specializing in the development of ZeDoc, a cloud-based platform that facilitates the collection and analysis of patient-reported outcome measures (PROMs). Founded in 2015 and headquartered in Auckland, New Zealand, with an additional office in Singapore, the company aims to enhance patient engagement and care outcomes while improving organizational efficiency and reducing costs. ZeDoc integrates seamlessly into existing clinical workflows, utilizing artificial intelligence-driven chatbots and data science techniques to minimize the burden of patient questioning. The platform allows healthcare providers to monitor real-time data from various health tracking devices and wearables, supporting the assessment of multiple patient cohorts and the identification of at-risk cases. By enabling effective communication between patients and care teams, The Clinician promotes a patient-centric, value-based care approach throughout the patient care continuum.

Neucruit is a government-backed venture that utilizes deep tech to build digital patient recruitment strategies to improve the lives of patients and clinical innovators. The London, England-based company was founded in 2019.

Tag.bio is a data analytics startup. It combines sophisticated statistical analysis methods with the organic intelligence of its users to find insights in any dataset. Individuals can use its point and click system to perform analysis and share results from enterprise and public datasets. It allows its users to make their own custom protocols to enterprise and public datasets. The platform is available for operations through iOS and Android applications. Tag.bio is a U.S.-based company that was founded in 2013 by Tom Covington and Jesse Paquette.

Droice Labs is an AI company specializing in understanding real-world clinical data to solve problems across the healthcare system. Our solutions provide answers to the key questions that healthcare entities have, helping them to make optimal decisions and to better understand diseases and the patients they affect. Our products use state of the art AI to help identify undiagnosed/misdiagnosed/mistreated patient populations. The insights are valuable for all stakeholders in healthcare: hospitals gain revenue in risk-sharing contracts, payers save money through increasing care efficiency, and life sciences identifies populations where their therapies perform appropriately. We use this technology to help payers, providers and hospital finance teams to fill documentation correctly, capture missed revenue, and fill care gaps. With our deep patient and disease understanding engine, we also help payers detect over-billing, design better plans and prioritize the right interventions to cover.

Liyfe is a telemedicine platform focused on cancer care, offering services such as personalized triage pathways for oncology patients. Utilizing an AI-based digital nurse chatbot, Liyfe automates symptom management and enhances the detection of high-risk patients. The platform provides a membership program that allows patients unlimited access to nurse practitioners via text and video chat for a monthly fee comparable to a co-pay. This service ensures 24/7 virtual care, facilitating timely medical support. Additionally, Liyfe's user-friendly electronic medical record (EMR) system allows patients to store and access their medical history securely. The platform is designed to educate patients on home symptom management while addressing their nutritional and emotional needs, thereby improving overall patient care and experience.

Prism is a software company operating a centralized, clinical trial meta-data platform. Our technology delivers contextualized trial data and insights. This leads to better trials, better evidence, and more effective decision-making. Prism was co-founded in Boston, Massachusetts by Spencer Hey and Brendan Guerin in 2019. Although coming from different worlds—Spencer from academia and Brendan from investing—the two connected after Brendan read Spencer’s STAT News article titled “New insights from a bird's-eye view of clinical trials”. The two quickly bonded over a shared drive to make the world of clinical research more efficient and effective. After countless hours of discussion and white boarding sessions, Prism was born to make this vision a reality.

SmartTab is a pharmaceutical company that focuses on developing the Smart Drug Delivery and Monitoring Systems. Its platform technology is a wireless ingestible capsule containing an electronic receiver, smart polymer actuator, and active ingredients. The company is focused on the development of three drug delivery platforms, TargetTab™, InjectTab™ and MultiTab™. The company was founded in 2015 and headquartered in Denver, Colorado, United States.

Developer of a blockchain-based personal data marketplace designed to store and monetize data. The company's marketplace uses personal health data transformed into a token that helps in currency generation, storing data securely, tracking health, and facilitating direct interactions between buyers and sellers, enabling pharmaceutical businesses to develop new drugs and individuals to sell their data securely and privately.

EVOCAL Health is a digital diagnostics company focused on utilizing vocal biomarkers and artificial intelligence to enhance disease detection and health monitoring. By developing advanced healthcare intelligence algorithms, the company analyzes voice, breathing, and coughing sounds to identify potential health issues. This innovative approach aims to transform disease detection through its accuracy, speed, and cost-effectiveness, making it accessible to a broader population. By leveraging everyday technology such as smartphones, EVOCAL Health seeks to democratize healthcare, enabling users to detect and diagnose diseases on a global scale and from virtually anywhere.

nQ Medical Inc., founded in 2016 and based in Cambridge, Massachusetts, specializes in developing innovative solutions for the detection and management of neurocognitive and neuromotor disorders. The company has created neuroQWERTY, an artificial intelligence tool that passively collects data through everyday use of electronic devices, enabling 24/7 monitoring of disease progression and therapeutic effectiveness. This frictionless and non-invasive platform captures subtle changes in user interactions, such as typing and touchscreen behavior, which are often overlooked by traditional clinical assessments. With proven capabilities demonstrated in extensive clinical trials, nQ Medical aims to facilitate early detection of disorders like Alzheimer's, Parkinson's, and multiple sclerosis, while offering a cost-effective alternative to current diagnostic methods. By providing patients and clinicians with a reliable means to track disease status and treatment impact, nQ Medical is positioned to enhance the management of neurological conditions significantly.